Arctic Therapeutics Raises $28.9M to Advance Dementia Care and Revolutionize Neurodegenerative Treatment

Arctic Therapeutics, a pioneering biotech company focused on developing innovative solutions for dementia, has successfully raised $28.9 million in its Series A funding round. This substantial investment aims to accelerate the development of groundbreaking treatments, offering hope to millions affected by dementia worldwide. Dementia is a debilitating condition that significantly impacts memory, cognition, and daily functioning. Currently, over 55 million people globally suffer from this condition. Existing treatments primarily manage symptoms rather than address the underlying causes. Arct